Immunicum AB (publ) Announces Publication of Abstracts for the 2020 ASCO-SITC Clinical Immuno-Oncology Symposium

NEXT STORY
Athenex CEO Informs Shareholders of Unrelated Matter Regarding Past Board Membership at Porton Pharma
PREV STORY
Black Diamond Therapeutics Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Sensus Healthcare to Host Second Quarter 2019 Financial Results and Business Update Conference Call on August 8, 2019

author_avatar
NASDAQ Market News

Michael Didocha Joins Telix as Chief Financial Officer, Americas

author_avatar
NASDAQ Market News

Immunicum AB (publ) Announces Update on Survival Data from Phase II MERECA Trial of Ilixadencel in Kidney Cancer

author_avatar
NASDAQ Market News